How to buy Rubrik (RBRK) stock from India

Yes, an Indian resident can buy Rubrik — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. For a company that only IPO'd in April 2024, the 90% is tax, estate-tax exposure, and position sizing. RBRK pays no dividend, so US withholding and Form 67 are a non-issue. This is the short version.

The 30-second version

• Legal and simple. Buy RBRK via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
• Pure capital-gains play. RBRK has never paid a dividend and won't anytime soon — it's a young, unprofitable growth company reinvesting every dollar — so US dividend withholding and Form 67 are irrelevant.
• India tax: hold more than 24 months and pay 12.5% LTCG (no indexation); sell sooner and pay your slab rate. This is Section 112, not the friendlier 112A that Indian shares get.
• The trap most miss: directly-held RBRK is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• A young public company. RBRK IPO'd April 2024 — barely 18 months of public data, lockup-and-secondary supply still in play, price has been volatile. Satellite-sized speculative bet, not a core holding.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	RBRK / NYSE
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	Fractional share (lets you invest an exact rupee amount)
Dividend	None — young growth company, no plan to start
India tax on gains	12.5% LTCG after 24 months; else slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. File your W-8BEN during onboarding — still good practice with no current dividend, since it covers any future distribution. New to this? Start with how to invest in US stocks from India.
2. Fund via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. RBRK has traded in a wide band between the $50s and $100s since its April 2024 IPO — a whole share is affordable, or buy a fractional rupee amount. Use a limit order: recent IPOs can move several percent on light volume.

The tax that actually matters

Rubrik pays no dividend, so the 25% US withholding and annual Form 67 dance — a headache with names like Microsoft or Apple — doesn't apply here. Your entire tax exposure is on capital gains under Section 112 (foreign shares don't get the 112A treatment Indian equity enjoys). Section 112 applies to recent IPOs the same way it applies to decades-old megacaps:

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 20 shares at $70 when USD/INR is 86 → cost 1,20,400 rupees. Sell 26 months later at $95 when USD/INR is 88 → proceeds 1,67,200 rupees. Taxable gain 46,800 rupees; LTCG at 12.5% = 5,850 rupees. A weaker rupee at sale amplifies the rupee gain. Be honest: RBRK is volatile and $45 is just as plausible as $95 — Section 112 also lets you book a loss against other foreign-share gains. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India. For Form 67 context, see dividend withholding and Form 67.

The $60,000 estate-tax trap

Directly-held RBRK is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no relief. The fix (pooled or fund structures rather than direct shares) has to be a deliberate choice before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Rubrik through an ETF?

If you want…	Best route
A concentrated bet on cyber-resilience and Rubrik specifically	RBRK directly
Broad US software / cybersecurity exposure	IGV (software) or HACK / CIBR (cybersecurity ETFs)
Total-market exposure that just touches RBRK	VTI — but the weight is tiny
The least single-stock risk	A broad ETF

The honest catch: because RBRK only listed in April 2024, it sits in VTI at a tiny weight and in software/cyber baskets like IGV, HACK and CIBR — none of which give concentrated RBRK exposure. If your thesis is "Rubrik wins cyber-resilience," only direct ownership delivers it; if it's "cybersecurity wins," HACK/CIBR is cleaner. Compare in direct stocks vs US ETFs and best US ETFs for Indian investors; broader case in US ETFs for Indians.

The business in one screen

What it is: Rubrik sells a "Zero Trust Data Security" platform — cyber-resilience and ransomware recovery for enterprise data across cloud, SaaS (M365, Salesforce), and on-prem. It has pivoted from hardware-anchored backup to subscription-first cloud data-security; subscription ARR has grown strongly post-IPO, but the business is still GAAP loss-making.

Bull case	Bear case
Cyber-resilience and ransomware recovery is a real, growing category	GAAP unprofitable; path to profit not yet proven
"Zero Trust Data Security" resonates with CISOs and boards	Cohesity (post-Veritas) and Commvault are credible competitors
Subscription ARR compounding fast post-IPO	~18 months of public data; lockup-and-secondary supply overhang
AI-data-protection narrative as enterprise AI rolls out	Customer concentration and cybersecurity-budget consolidation in tight IT cycles

Exact valuation is in the live widget above — a high-growth, still-unprofitable cyber-resilience name, priced on revenue not earnings.

Our take

Verdict: HOLD — real category, real product, real growth, but too young and too unprofitable to size as a quality compounder.

• The category is genuine. Ransomware and data-extortion attacks have made cyber-resilience — not just prevention — a board-level priority. Rubrik's positioning is credible and the CISO conversation is favourable.
• Financials aren't there yet. GAAP losses, heavy stock-based comp, and the recent-IPO pattern of lockup releases and employee secondaries mean supply can override fundamentals for stretches. Cohesity (post-Veritas) and Commvault aren't going away; Veeam is the entrenched incumbent.
• Speculative growth, not core. Fits as a small satellite for someone who specifically wants concentrated cyber-resilience exposure and accepts 30-50% drawdowns. If your thesis is "cybersecurity wins," HACK or CIBR delivers the category without single-name risk. Holding, not buying more, until two-to-three quarters of operating-leverage progress show up.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Unprofitability and dilution: GAAP-unprofitable with meaningful stock-based comp; share count drifts up until operating leverage arrives.
• Lockup and secondary supply: post-IPO employee and pre-IPO investor selling can weigh on price independent of fundamentals well into year two and three.
• Competition: Cohesity (post-Veritas), Commvault, and Veeam all chase the same cyber-resilience and backup-modernisation budget.
• Customer concentration and IT budget cycles: early-stage growth means lumpy enterprise deal flow, and in tighter cybersecurity-spending environments CISOs consolidate vendors — compressing new-logo growth even when product wins bake-offs.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose RBRK in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. No dividend means you skip Form 67 — but Schedule FA is non-negotiable. Use the Schedule FA helper.
• Position size: a young, unprofitable, single-vendor cyber-resilience bet is not an index. Size RBRK as a small speculative satellite, not a substitute for a broad ETF or a cybersecurity basket.

Bottom line

Buying RBRK from India is easy and legal. What needs thought is that RBRK is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap, and a young, volatile, unprofitable single-vendor cyber-resilience story with barely 18 months of public data. The upside: no dividend means no 25% withholding and no Form 67. If your real thesis is "cybersecurity wins," HACK or CIBR gives the category without the single-name risk. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.